Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05424406 · ClinicalTrials.gov registry record · NA
Role of Sleep Reactivity in Shift Work Disorder
A NA study of Shift-work Disorder, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05424406 is a NA study of Shift-work Disorder that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 150 participants, below the 208-participant average among 3 other Shift-work Disorder trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05424406, a NA study of Shift-work Disorder, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to test sleep reactivity as an independent cause of Shift Work Disorder (SWD). The primary hypothesis is that those with high sleep reactivity will show persistent SWD symptoms after experimental reduction of circadian misalignment, which will then be mitigated with CBT.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- BEHAVIORAL Active phototherapy
- BEHAVIORAL Control phototherapy
- BEHAVIORAL Sleep education control
Study Locations (1)
Michigan
- Henry Ford Columbus Medical Center - Novi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05424406
The ClinicalTrials.gov registry entry for NCT05424406 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 208-participant average among 3 other Shift-work Disorder trials with a reported enrollment target (28% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Shift-work Disorder appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT05424406 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05424406 about?
NCT05424406 is a clinical study titled "Role of Sleep Reactivity in Shift Work Disorder". The purpose of this project is to test sleep reactivity as an independent cause of Shift Work Disorder (SWD). The primary hypothesis is that those with high sleep reactivity will show persistent SWD symptoms after experimental reduction of circadian misalignment, which will then be mitigated with CB...
What is the current status of trial NCT05424406?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-01-01. Estimated completion is 2027-10-01.
What conditions does trial NCT05424406 study?
This clinical trial studies the following conditions: Shift-work Disorder.
What interventions are being tested in trial NCT05424406?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Active phototherapy (BEHAVIORAL), Control phototherapy (BEHAVIORAL), Sleep education control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05424406?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05424406 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shift-work Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.